INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$3.74
−6.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.45x
- Price / sales
- 0.66x
- Price / cash flow
- 5.67x
Enterprise value
- Enterprise value
- $99.1M
- EV / sales
- 1.16x
- EV / EBITDA
- -5.95x
- EV / EBIT
- -11.52x
- Market cap
- $56.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025